Brazil’s health ministry recently announced its plan to breed genetically modified mosquitoes to stop the spread of dengue fever. According to news reports, scientists are focusing intensely on mosquito control because there is currently no vaccine to protect against dengue.
The Centers for Disease Control and Prevention recently announced its development of a new diagnostic test to detect the presence of the dengue virus.

This month, the Sabin Vaccine Institute will begin a Phase-1 clinical trial in Washington, DC to further investigate the Na-GST-1 human hookworm vaccine candidate.

Each year since 1994 the Sabin Vaccine Institute has  recognized distinguished members of the scientific community  with its highest honor, the Albert B. Sabin Gold Medal Award.  Gold Medal Award winners have made significant contributions  to vaccinology or a complementary field.

Pages